PATENT INFRINGEMENT cases are inevitable in the pharma industry. Lawsuits are filed more often than new drugs are discovered and every modification of a drug results in more patents and, predictably, more infringement suits. These take years to be settled, but since the damages awarded by the courts can be astronomical in the US, well-heeled drug majors have an incentive to pursue aggressive litigation. Legal costs don't matter much to the big firms, since their market monopoly allows them to rake in millions, if not billions, of dollars in profit.
Developments in recent months may well alter the course of litigation, and it could perhaps make the drug patent battles less problematic for Indian generics, for whom the US is the most lucrative market. This is the entry of the US Federal Trade Commission (FTC) in the knotty question of patents. FTC's primary role is to enforce consumer protection laws aimed at preventing fraud and unfair business practices, but it also enforces federal antitrust laws that "prohibit anticompetitive mergers and other business practices that could lead to higher prices, fewer choices, or less innovation." Possibly because of the Joe Biden Administration's interest in bringing down healthcare costs, FTC is now looking at drug patents from the latter aspect.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
A SPRIG TO CARE FOR
Punarnava, a perennial herb, is easy to grow and has huge health benefits
DIGGING A DISASTER
Soapstone mining near Dabti Vijaypur village has caused many residents to migrate.
REVIEW THE TREATMENT
Several faecal sludge treatment plants in Uttar Pradesh suffer from design flaws that make the treatment process both expensive and inefficient
MAKE STEEL SUSTAINABLE
As India works to double its GDP by 2030, its steel industry must balance growth with sustainability. By embracing policies like the Steel Scrap Recycling Policy 2019 and adopting green technologies, India is paving the way for a more sustainable future in steel production
Can ANRF pull off the impossible for India?
Anusandhan National Research Foundation is expected to reorient India's innovation goals but funding issues, old mindsets remain a drag
TROUBLED WOODS
Forests are a great bulwark against climate change. But this is fast changing. AKSHIT SANGOMLA travels through some of the pristine patches of the Western Ghats to explore how natural disturbances triggered by global warming now threaten the forest health
BLINDING GLOW
The science is clear: increased illumination has damaging consequences for the health of humans, animals and plants. It’s time governments introduced policies to protect the natural darkness and improved the quality of outdoor lighting.
GROUND REALITY
What happens when the soil loses the ability to grow healthy, high-yield crops on its own?
GM POLICY MUST BE FARMER CENTRIC
On July 23, the Supreme Court of India directed the Union government to develop a national policy on genetically modified (GM) crops for research, cultivation, trade and commerce through public consultation.
Vinchurni's Gandhi
A 96-year-old farmer transforms barren land into a thriving forest in drought-prone region of Satara